
▪ | Assets under management end quarter at $1.21 trillion |
▪ | Net client inflows of $2.8 billion for Q4 2019 and $13.2 billion for 2019 |
▪ | Net revenues of $1.5 billion for Q4 2019 and $5.6 billion for 2019 |
▪ | Diluted earnings per common share of $2.24 for Q4 2019 and $8.70 for 2019 |
▪ | Adjusted non-GAAP diluted earnings per common share of $2.03 for Q4 2019 and $8.07 for 2019 |
▪ | Long-term investment performance remains strong |
Three Months ended | Year ended | ||||||||||||||||||||||
(in millions, except per-share data) | 12/31/2019 | 12/31/2018 | % change | 12/31/2019 | 12/31/2018 | % change | |||||||||||||||||
U.S. GAAP basis | |||||||||||||||||||||||
Investment advisory fees | $ | 1,344.7 | $ | 1,183.7 | 13.6 | % | $ | 5,112.5 | $ | 4,850.6 | 5.4 | % | |||||||||||
Net revenues | $ | 1,468.7 | $ | 1,305.0 | 12.5 | % | $ | 5,617.9 | $ | 5,372.6 | 4.6 | % | |||||||||||
Operating expenses | $ | 888.4 | $ | 762.7 | 16.5 | % | $ | 3,230.9 | $ | 3,011.2 | 7.3 | % | |||||||||||
Net operating income | $ | 580.3 | $ | 542.3 | 7.0 | % | $ | 2,387.0 | $ | 2,361.4 | 1.1 | % | |||||||||||
Non-operating income (loss)(1) | $ | 170.0 | $ | (151.9 | ) | n/m | $ | 540.3 | $ | 23.2 | n/m | ||||||||||||
Net income attributable to T. Rowe Price Group | $ | 545.3 | $ | 351.9 | 55.0 | % | $ | 2,131.3 | $ | 1,837.5 | 16.0 | % | |||||||||||
Diluted earnings per common share | $ | 2.24 | $ | 1.41 | 58.9 | % | $ | 8.70 | $ | 7.27 | 19.7 | % | |||||||||||
Weighted average common shares outstanding assuming dilution | 237.4 | 242.9 | (2.3 | )% | 238.6 | 246.9 | (3.4 | )% | |||||||||||||||
Adjusted non-GAAP basis(2) | |||||||||||||||||||||||
Operating expenses | $ | 863.5 | $ | 794.7 | 8.7 | % | $ | 3,149.8 | $ | 3,025.5 | 4.1 | % | |||||||||||
Net operating income | $ | 605.7 | $ | 511.9 | 18.3 | % | $ | 2,474.9 | $ | 2,353.3 | 5.2 | % | |||||||||||
Non-operating income(1) | $ | 27.2 | $ | 2.8 | n/m | $ | 126.0 | $ | 28.5 | n/m | |||||||||||||
Net income attributable to T. Rowe Price Group | $ | 495.2 | $ | 384.0 | 29.0 | % | $ | 1,975.6 | $ | 1,807.4 | 9.3 | % | |||||||||||
Diluted earnings per common share | $ | 2.03 | $ | 1.54 | 31.8 | % | $ | 8.07 | $ | 7.15 | 12.9 | % | |||||||||||
Assets under Management (in billions) | |||||||||||||||||||||||
Average assets under management | $ | 1,162.0 | $ | 1,011.3 | 14.9 | % | $ | 1,109.3 | $ | 1,036.5 | 7.0 | % | |||||||||||
Ending assets under management | $ | 1,206.8 | $ | 962.3 | 25.4 | % | $ | 1,206.8 | $ | 962.3 | 25.4 | % | |||||||||||
▪ | The SEC's approval of our application for semi-transparent active ETFs. As a next step, the NYSE Arca filed an application with the SEC under Rule 19b-4 in December in order to amend its trading rules to list our semi-transparent ETFs. We also filed registration statements with the SEC for our products and hope to be in market in 2020 with four of our flagship U.S. equity strategies - Blue Chip Growth, Growth Stock, Dividend Growth, and Equity Income. |
▪ | Continued development of our long-term strategic product pipeline and the launch of three new products for the firm - Growth Stock ITM, Dynamic Credit Fund SICAV, and China Evolution Equity Fund, our first mutual fund focused solely on Chinese equities. |
▪ | The launch of a number of new features and digital enhancements for our individual investor and recordkeeping clients. Specific to recordkeeping clients, we enhanced the participant homepage, which serves as the hub of our multichannel engagement experience, and announced an integrated health savings account solution in partnership with ConnectYourCare. |
Three months ended 12/31/2019 | Year ended 12/31/2019 | |||||||||||||||||||||||||||||||
(in billions) | U.S. mutual funds | Subadvised and separate accounts | Other investment products | Total | U.S. mutual funds | Subadvised and separate accounts | Other investment products | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 642.6 | $ | 293.0 | $ | 190.7 | $ | 1,126.3 | $ | 564.5 | $ | 250.0 | $ | 147.8 | $ | 962.3 | ||||||||||||||||
Net cash flows before client transfers | .4 | (.7 | ) | 3.1 | 2.8 | 7.6 | (.3 | ) | 5.9 | 13.2 | ||||||||||||||||||||||
Client transfers | (3.7 | ) | .3 | 3.4 | — | (23.2 | ) | 1.1 | 22.1 | — | ||||||||||||||||||||||
Net cash flows after client transfers | (3.3 | ) | (.4 | ) | 6.5 | 2.8 | (15.6 | ) | .8 | 28.0 | 13.2 | |||||||||||||||||||||
Net market appreciation (depreciation) and income | 45.1 | 21.2 | 13.1 | 79.4 | 135.6 | 63.0 | 34.5 | 233.1 | ||||||||||||||||||||||||
Net distributions reinvested (not reinvested) | (1.7 | ) | — | — | (1.7 | ) | (1.8 | ) | — | — | (1.8 | ) | ||||||||||||||||||||
Change during the period | 40.1 | 20.8 | 19.6 | 80.5 | 118.2 | 63.8 | 62.5 | 244.5 | ||||||||||||||||||||||||
Assets under management at December 31, 2019 | $ | 682.7 | $ | 313.8 | $ | 210.3 | $ | 1,206.8 | $ | 682.7 | $ | 313.8 | $ | 210.3 | $ | 1,206.8 | ||||||||||||||||
Three months ended 12/31/2019 | Year ended 12/31/2019 | |||||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Total | Equity | Fixed income, including money market | Multi-asset(1) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 643.5 | $ | 146.6 | $ | 336.2 | $ | 1,126.3 | $ | 539.9 | $ | 136.1 | $ | 286.3 | $ | 962.3 | ||||||||||||||||
Net cash flows | — | (.1 | ) | 2.9 | 2.8 | (.2 | ) | 3.5 | 9.9 | 13.2 | ||||||||||||||||||||||
Net market appreciation (depreciation) and income(2) | 55.4 | 1.4 | 20.9 | 77.7 | 159.2 | 8.3 | 63.8 | 231.3 | ||||||||||||||||||||||||
Change during the period | 55.4 | 1.3 | 23.8 | 80.5 | 159.0 | 11.8 | 73.7 | 244.5 | ||||||||||||||||||||||||
Assets under management at December 31, 2019 | $ | 698.9 | $ | 147.9 | $ | 360.0 | $ | 1,206.8 | $ | 698.9 | $ | 147.9 | $ | 360.0 | $ | 1,206.8 | ||||||||||||||||
▪ | Investment advisory revenues earned in Q4 2019 from the firm's U.S. mutual funds were $894.9 million, an increase of 9.4% from Q4 2018. Average assets under management in these funds increased 10.4% to $661.6 billion in Q4 2019. |
▪ | Investment advisory revenues earned in Q4 2019 from subadvised, separate accounts, and other investment products were $449.8 million, an increase of 23.0% from Q4 2018. Average assets under management for these products increased 21.4% to $500.4 billion in Q4 2019. |
▪ | The effective fee rate of 45.9 basis points in Q4 2019 slightly increased compared to the 45.8 basis points earned in Q3 2019, though decreased from the 46.4 basis points in Q4 2018. The decline in the effective fee rate from Q4 2018 is largely due to client transfers to lower fee vehicles or share classes over the last twelve months and, to a lesser extent, fee reductions made to certain mutual funds and other products since Q4 2018. Over time, the firm's effective fee rate can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures. |
▪ | Administrative, distribution, and servicing fees in Q4 2019 were $124.0 million, an increase of 2.2% from |
▪ | Compensation and related costs were $528.2 million in Q4 2019, an increase of 15.6% over Q4 2018. This increase was primarily related to higher compensation expense related to the supplemental savings plan given the strong equity market returns experienced in Q4 2019 compared with the sharp equity market declines in Q4 2018. Also contributing to the increase was a 4.3% growth in average headcount and higher bonus and stock-based compensation expense. The firm employed 7,365 associates at |
▪ | Advertising and promotion expenses were $38.3 million in Q4 2019, an increase of 7.0% over Q4 2018. The increase was primarily driven by increased media activity in Q4 2019 compared to Q4 2018. |
▪ | Technology, occupancy, and facility costs were $117.8 million in Q4 2019, an increase of 17.7% from the $100.1 million recognized in Q4 2018. The increase was due to incremental investment in the firm's technology capabilities, including related depreciation and hosted solution licenses, as well as non-recurring office facility costs. |
▪ | General, administrative, and other costs were $99.3 million in Q4 2019, an increase of 28.6% compared with the $77.2 million recognized in Q4 2018. The increase was primarily due to higher professional fees and third-party investment research costs. |
Three months ended | Year ended | |||||||||||
12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | |||||||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||
Impact of nonrecurring charge related to U.S. tax reform recognized in the second quarter | — | — | — | .8 | ||||||||
Impact of nonrecurring charge related to new Maryland state tax legislation recognized in the second quarter | — | — | — | .3 | ||||||||
State income taxes for current year, net of federal income tax benefits(1) | 4.1 | 4.9 | 4.3 | 4.6 | ||||||||
Net income attributable to redeemable non-controlling interests | (2.0 | ) | 5.9 | (1.0 | ) | .7 | ||||||
Net excess tax benefits from stock-based compensation plans activity | (3.2 | ) | (1.4 | ) | (1.5 | ) | (1.7 | ) | ||||
Other items | .9 | (.1 | ) | .4 | .1 | |||||||
Effective income tax rate | 20.8 | % | 30.3 | % | 23.2 | % | 25.8 | % | ||||
(in millions) | 12/31/2019 | 12/31/2018 | ||||||
Cash and cash equivalents | $ | 1,781.8 | $ | 1,425.2 | ||||
Discretionary investments | 1,899.6 | 1,597.1 | ||||||
Total cash and discretionary investments | 3,681.4 | 3,022.3 | ||||||
Redeemable seed capital investments | 1,325.6 | 1,118.9 | ||||||
Investments used to hedge the supplemental savings plan liability | 561.1 | 381.3 | ||||||
Total cash and investments in T. Rowe Price products | $ | 5,568.1 | $ | 4,522.5 | ||||
▪ | The firm's common shares outstanding were 235.2 million at December 31, 2019, compared with 238.1 million at the end of 2018. |
▪ | In 2019, the firm expended $708.8 million to repurchase 7.0 million shares, or 2.9%, of its outstanding common shares at an average price of $101.65, including $142.0 million to repurchase 1.3 million shares during Q4 2019 at an average price of $110.89. |
▪ | The firm invested $204.6 million during the full year ended 2019 in capitalized facilities and technology and expects capital expenditures for 2020 to be up to $210 million, of which about three-quarters is planned for technology initiatives. These expenditures are expected to continue to be funded from the firm's operating resources. |
1 year | 3 years | 5 years | 10 years | |||||
Outperformed Morningstar median | ||||||||
All funds | 64% | 75% | 80% | 82% | ||||
Multi-asset funds | 69% | 85% | 94% | 95% | ||||
Top Morningstar quartile | ||||||||
All funds | 32% | 45% | 50% | 55% | ||||
Multi-asset funds | 36% | 59% | 65% | 74% | ||||
Public Relations | Investor Relations | ||
Brian Lewbart | Meghan Azevedo | ||
410-345-2242 | 410-345-2756 | ||
brian.lewbart@troweprice.com | meghan.azevedo@troweprice.com | ||
Unaudited Consolidated Statements of Income | |||||||||||||||||
(in millions, except per-share amounts) | |||||||||||||||||
Three months ended | Year ended | ||||||||||||||||
Revenues | 12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | |||||||||||||
Investment advisory fees | $ | 1,344.7 | $ | 1,183.7 | $ | 5,112.5 | $ | 4,850.6 | |||||||||
Administrative, distribution, and servicing fees | 124.0 | 121.3 | 505.4 | 522.0 | |||||||||||||
Net revenues | 1,468.7 | 1,305.0 | 5,617.9 | 5,372.6 | |||||||||||||
Operating expenses | |||||||||||||||||
Compensation and related costs | 528.2 | 456.9 | 1,969.2 | 1,808.6 | |||||||||||||
Distribution and servicing | 67.2 | 67.9 | 262.5 | 281.2 | |||||||||||||
Advertising and promotion | 38.3 | 35.8 | 96.8 | 99.6 | |||||||||||||
Product-related costs | 37.6 | 40.0 | 153.2 | 157.1 | |||||||||||||
Technology, occupancy, and facility costs | 117.8 | 100.1 | 427.3 | 383.9 | |||||||||||||
General, administrative, and other | 99.3 | 77.2 | 321.9 | 296.0 | |||||||||||||
Nonrecurring recoveries related to Dell appraisal rights matter | — | (15.2 | ) | — | (15.2 | ) | |||||||||||
Total operating expenses | 888.4 | 762.7 | 3,230.9 | 3,011.2 | |||||||||||||
Net operating income | 580.3 | 542.3 | 2,387.0 | 2,361.4 | |||||||||||||
Non-operating income (loss) | |||||||||||||||||
Net gains (losses) on investments | 66.4 | (28.7 | ) | 260.4 | 119.2 | ||||||||||||
Net gains (losses) on consolidated investment products | 96.6 | (121.5 | ) | 272.9 | (92.9 | ) | |||||||||||
Other income (loss) | 7.0 | (1.7 | ) | 7.0 | (3.1 | ) | |||||||||||
Total non-operating income (loss) | 170.0 | (151.9 | ) | 540.3 | 23.2 | ||||||||||||
Income before income taxes | 750.3 | 390.4 | 2,927.3 | 2,384.6 | |||||||||||||
Provision for income taxes | 156.4 | 118.4 | 678.4 | 615.9 | |||||||||||||
Net income | 593.9 | 272.0 | 2,248.9 | 1,768.7 | |||||||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | 48.6 | (79.9 | ) | 117.6 | (68.8 | ) | |||||||||||
Net income attributable to T. Rowe Price Group | 545.3 | 351.9 | 2,131.3 | 1,837.5 | |||||||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 14.6 | 8.8 | 55.3 | 43.6 | |||||||||||||
Net income allocated to T. Rowe Price Group common stockholders | $ | 530.7 | $ | 343.1 | $ | 2,076.0 | $ | 1,793.9 | |||||||||
Earnings per share | |||||||||||||||||
Basic | $ | 2.27 | $ | 1.43 | $ | 8.82 | $ | 7.41 | |||||||||
Diluted | $ | 2.24 | $ | 1.41 | $ | 8.70 | $ | 7.27 | |||||||||
Weighted-average common shares | |||||||||||||||||
Outstanding | 234.1 | 239.7 | 235.4 | 242.2 | |||||||||||||
Outstanding assuming dilution | 237.4 | 242.9 | 238.6 | 246.9 | |||||||||||||
Investment Advisory Revenues (in millions) | Three months ended | Year ended | ||||||||||||||
12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | |||||||||||||
U.S. mutual funds | ||||||||||||||||
Equity and blended assets | $ | 766.9 | $ | 689.1 | $ | 2,952.2 | $ | 2,858.1 | ||||||||
Fixed income, including money market | 128.0 | 128.8 | 500.3 | 516.9 | ||||||||||||
894.9 | 817.9 | 3,452.5 | 3,375.0 | |||||||||||||
Subadvised and separate accounts and other investment products | ||||||||||||||||
Equity and blended assets | 384.2 | 305.8 | 1,405.0 | 1,236.8 | ||||||||||||
Fixed income, including money market | 65.6 | 60.0 | 255.0 | 238.8 | ||||||||||||
449.8 | 365.8 | 1,660.0 | 1,475.6 | |||||||||||||
Total | $ | 1,344.7 | $ | 1,183.7 | $ | 5,112.5 | $ | 4,850.6 | ||||||||
Assets Under Management (in billions) | Average during | ||||||||||||||||||||||||
Three months ended | Year ended | As of | |||||||||||||||||||||||
12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | ||||||||||||||||||||
U.S. mutual funds | |||||||||||||||||||||||||
Equity and blended assets | $ | 531.7 | $ | 472.0 | $ | 513.6 | $ | 493.6 | $ | 552.4 | $ | 441.1 | |||||||||||||
Fixed income, including money market | 129.9 | 127.1 | 126.8 | 128.2 | 130.3 | 123.4 | |||||||||||||||||||
661.6 | 599.1 | 640.4 | 621.8 | 682.7 | 564.5 | ||||||||||||||||||||
Subadvised and separate accounts and other investment products | |||||||||||||||||||||||||
Equity and blended assets | 389.8 | 313.9 | 362.5 | 317.3 | 412.1 | 299.2 | |||||||||||||||||||
Fixed income, including money market | 110.6 | 98.3 | 106.4 | 97.4 | 112.0 | 98.6 | |||||||||||||||||||
500.4 | 412.2 | 468.9 | 414.7 | 524.1 | 397.8 | ||||||||||||||||||||
Total | $ | 1,162.0 | $ | 1,011.3 | $ | 1,109.3 | $ | 1,036.5 | $ | 1,206.8 | $ | 962.3 | |||||||||||||
Net Cash Flows After Client Transfers (by investment vehicle and underlying asset class)(1)(2) | Three months ended | Year ended | ||||||
(in billions) | 12/31/2019 | 12/31/2019 | ||||||
U.S. mutual funds | ||||||||
Equity and blended assets | $ | (3.2 | ) | $ | (13.9 | ) | ||
Fixed income, including money market | (.1 | ) | (1.7 | ) | ||||
(3.3 | ) | (15.6 | ) | |||||
Subadvised and separate accounts and other investment products | ||||||||
Equity and blended assets | 5.7 | 22.4 | ||||||
Fixed income, including money market | .4 | 6.4 | ||||||
6.1 | 28.8 | |||||||
Total net cash flows after client transfers | $ | 2.8 | $ | 13.2 | ||||
Non-Operating Income (Loss) (in millions) | Three months ended | Year ended | ||||||||||||||
12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | |||||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | ||||||||||||||||
Cash and discretionary investments | ||||||||||||||||
Dividend income | $ | 15.4 | $ | 17.8 | $ | 67.6 | $ | 48.8 | ||||||||
Market related gains (losses) and equity in earnings | 11.8 | (15.0 | ) | 58.4 | (16.0 | ) | ||||||||||
Seed capital investments | ||||||||||||||||
Dividend income | 1.3 | 1.2 | 2.3 | 3.9 | ||||||||||||
Market related gains (losses) and equity in earnings | 11.8 | (17.0 | ) | 42.7 | (22.5 | ) | ||||||||||
Net gain (loss) recognized upon deconsolidation | — | — | .1 | 3.6 | ||||||||||||
Investments used to hedge the supplemental savings plan liability | 23.1 | (20.3 | ) | 67.9 | (6.1 | ) | ||||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 63.4 | (33.3 | ) | 239.0 | 11.7 | |||||||||||
Other investment income | 3.0 | 4.6 | 21.4 | 107.5 | ||||||||||||
Net gains (losses) on investments | 66.4 | (28.7 | ) | 260.4 | 119.2 | |||||||||||
Net gains (losses) on consolidated sponsored investment portfolios | 96.6 | (121.5 | ) | 272.9 | (92.9 | ) | ||||||||||
Other income (loss), including foreign currency gains and losses | 7.0 | (1.7 | ) | 7.0 | (3.1 | ) | ||||||||||
Non-operating income (loss) | $ | 170.0 | $ | (151.9 | ) | $ | 540.3 | $ | 23.2 | |||||||
Unaudited Condensed Consolidated Cash Flows Information (in millions) | ||||||||||||||||||||||||
Year ended | ||||||||||||||||||||||||
12/31/2019 | 12/31/2018 | |||||||||||||||||||||||
Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | |||||||||||||||||||
Cash provided by (used in) operating activities, including $206.6 of stock-based compensation expense and $190.8 of depreciation expense in 2019 | $ | 2,202.3 | $ | (679.6 | ) | $ | 1,522.7 | $ | 2,178.1 | $ | (558.2 | ) | $ | 1,619.9 | ||||||||||
Cash provided by (used in) investing activities, including $(204.6) for additions to property and equipment and $(239.7) of additions to T. Rowe Price investment products in 2019 | (489.3 | ) | 164.8 | (324.5 | ) | (945.7 | ) | 70.2 | (875.5 | ) | ||||||||||||||
Cash provided by (used in) financing activities, including T. Rowe Price Group common stock repurchases of $(705.8)* and dividends paid of $(733.9) in 2019 | (1,356.4 | ) | 523.7 | (832.7 | ) | (1,709.9 | ) | 470.4 | (1,239.5 | ) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | (2.5 | ) | (2.5 | ) | — | (15.4 | ) | (15.4 | ) | ||||||||||||||
Net change in cash and cash equivalents during period | $ | 356.6 | $ | 6.4 | $ | 363.0 | $ | (477.5 | ) | $ | (33.0 | ) | $ | (510.5 | ) | |||||||||
Unaudited Condensed Consolidated Balance Sheet Information (in millions) | As of | |||||||
12/31/2019 | 12/31/2018 | |||||||
Cash and cash equivalents | $ | 1,781.8 | $ | 1,425.2 | ||||
Accounts receivable and accrued revenue | 646.6 | 549.6 | ||||||
Investments | 2,939.8 | 2,453.4 | ||||||
Assets of consolidated T. Rowe Price investment products | 2,276.9 | 1,680.4 | ||||||
Operating lease assets | 110.8 | — | ||||||
Property and equipment, net | 674.4 | 661.3 | ||||||
Goodwill | 665.7 | 665.7 | ||||||
Other assets | 234.4 | 253.7 | ||||||
Total assets | 9,330.4 | 7,689.3 | ||||||
Supplemental savings plan liability | 563.4 | 380.0 | ||||||
Total other liabilities, includes $39.2 at December 31, 2019, and $38.7 at December 31, 2018, from consolidated T. Rowe Price investment products | 543.9 | 444.7 | ||||||
Redeemable non-controlling interests | 1,121.0 | 740.3 | ||||||
Stockholders' equity, 235.2 common shares outstanding at December 31, 2019 | $ | 7,102.1 | $ | 6,124.3 | ||||
Cash, Cash Equivalents, and Investments Information (in millions) | ||||||||||||||||
Cash and cash equivalents | Investments | Net assets of consolidated T. Rowe Price investment products* | 12/31/2019 | |||||||||||||
Cash and discretionary investments | $ | 1,781.8 | $ | 1,831.8 | $ | 67.8 | $ | 3,681.4 | ||||||||
Seed capital investments | — | 276.7 | 1,048.9 | 1,325.6 | ||||||||||||
Investments used to hedge the supplemental savings plan liability | — | 561.1 | — | 561.1 | ||||||||||||
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group | 1,781.8 | 2,669.6 | 1,116.7 | 5,568.1 | ||||||||||||
Investment in UTI and other investments | — | 270.2 | — | 270.2 | ||||||||||||
Total cash and investments attributable to T. Rowe Price Group | 1,781.8 | 2,939.8 | 1,116.7 | 5,838.3 | ||||||||||||
Redeemable non-controlling interests | — | — | 1,121.0 | 1,121.0 | ||||||||||||
As reported on unaudited condensed consolidated balance sheet at December 31, 2019 | $ | 1,781.8 | $ | 2,939.8 | $ | 2,237.7 | $ | 6,959.3 | ||||||||
Three months ended 12/31/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(7) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(8) | ||||||||||||||||||
U.S. GAAP Basis | $ | 888.4 | $ | 580.3 | $ | 170.0 | $ | 156.4 | $ | 545.3 | $ | 2.24 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (3.6 | ) | 4.1 | (96.6 | ) | (12.0 | ) | (31.9 | ) | (.13 | ) | ||||||||||||
Supplemental savings plan liability(2) | (21.3 | ) | 21.3 | (23.1 | ) | (.4 | ) | (1.4 | ) | (.01 | ) | ||||||||||||
Other non-operating income(3) | — | — | (23.1 | ) | (6.3 | ) | (16.8 | ) | (.07 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 863.5 | $ | 605.7 | $ | 27.2 | $ | 137.7 | $ | 495.2 | $ | 2.03 | |||||||||||
Three months ended 12/31/2018 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(7) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(8) | ||||||||||||||||||
U.S. GAAP Basis | $ | 762.7 | $ | 542.3 | $ | (151.9 | ) | $ | 118.4 | $ | 351.9 | $ | 1.41 | ||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (1.9 | ) | 3.5 | 121.5 | 8.3 | 36.8 | .15 | ||||||||||||||||
Supplemental savings plan liability(2) | 18.7 | (18.7 | ) | 20.3 | .3 | 1.3 | — | ||||||||||||||||
Other non-operating income(3) | — | — | 12.9 | 6.4 | 6.5 | .03 | |||||||||||||||||
Recoveries related to Dell appraisal rights matter(6) | 15.2 | (15.2 | ) | — | (2.7 | ) | (12.5 | ) | (.05 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 794.7 | $ | 511.9 | $ | 2.8 | $ | 130.7 | $ | 384.0 | $ | 1.54 | |||||||||||
Year ended 12/31/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(7) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(8) | ||||||||||||||||||
U.S. GAAP Basis | $ | 3,230.9 | $ | 2,387.0 | $ | 540.3 | $ | 678.4 | $ | 2,131.3 | $ | 8.70 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (7.9 | ) | 14.7 | (272.9 | ) | (35.7 | ) | (104.9 | ) | (.42 | ) | ||||||||||||
Supplemental savings plan liability(2) | (73.2 | ) | 73.2 | (67.9 | ) | 1.3 | 4.0 | .02 | |||||||||||||||
Other non-operating income(3) | — | — | (73.5 | ) | (18.7 | ) | (54.8 | ) | (.23 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 3,149.8 | $ | 2,474.9 | $ | 126.0 | $ | 625.3 | $ | 1,975.6 | $ | 8.07 | |||||||||||
Year ended 12/31/2018 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(7) | ||||||||||||||||||
U.S. GAAP Basis | $ | 3,011.2 | $ | 2,361.4 | $ | 23.2 | $ | 615.9 | $ | 1,837.5 | $ | 7.27 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (6.5 | ) | 12.7 | 92.9 | 6.5 | 30.3 | .12 | ||||||||||||||||
Supplemental savings plan liability(2) | 5.6 | (5.6 | ) | 6.1 | .1 | .4 | — | ||||||||||||||||
Other non-operating income(3) | — | — | (93.7 | ) | (16.7 | ) | (77.0 | ) | (.30 | ) | |||||||||||||
Nonrecurring charge related to enactment of U.S. tax reform(4) | — | — | — | (20.8 | ) | 20.8 | .08 | ||||||||||||||||
Nonrecurring charge related to enactment of Maryland state tax legislation(5) | — | — | — | (7.9 | ) | 7.9 | .03 | ||||||||||||||||
Recoveries related to Dell appraisal rights matter(6) | 15.2 | (15.2 | ) | — | (2.7 | ) | (12.5 | ) | (.05 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 3,025.5 | $ | 2,353.3 | $ | 28.5 | $ | 574.4 | $ | 1,807.4 | $ | 7.15 | |||||||||||
(1) | These non-GAAP adjustments remove the impact the consolidated T. Rowe Price investment products have on the firm's U.S. GAAP consolidated statements of income. Specifically, the firm adds back the operating expenses and subtracts the investment income of the consolidated T. Rowe Price investment products. The adjustment to operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interests. Management believes the consolidated T. Rowe Price investment products may impact the reader’s ability to understand the firm's core operating results. |
(2) | This non-GAAP adjustment removes the compensation expense from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. The firm uses T. Rowe Price investment products to economically hedge the exposure to these market movements. Management believes it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period. |
(3) | This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on the firm's non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and, beginning in the second quarter of 2018, those non-consolidated investments that are not part of the cash and discretionary investment portfolio. In the second quarter of 2018, management decided to retain the investment gains recognized on the non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of the firm's core operations. The impact on previously reported non-GAAP measures is immaterial. Management believes adjusting for these non-operating income (loss) items helps the reader’s ability to understand the |
(4) | During the second quarter of 2018, the firm recognized a nonrecurring charge of $20.8 million for an adjustment made to the charge taken in 2017 related to the enactment of U.S. tax reform. Management believes it is useful to readers of its consolidated statements of income to adjust for this nonrecurring charge in arriving at net income attributable to T. Rowe Price Group and diluted earnings per share. |
(5) | During the second quarter of 2018, the firm recognized a nonrecurring charge of $7.9 million for the remeasurement of its deferred tax assets and liabilities to reflect the effect of Maryland state tax legislation enacted on April 24, 2018. Management believes it is useful to readers of its consolidated statements of income to adjust for this nonrecurring charge in arriving at net income attributable to T. Rowe Price Group and diluted earnings per share. |
(6) | Prior to 2018, we recognized a net $16.2 million non-recurring charge in operating expenses from compensation paid to clients and subsequent insurance recoveries related to the Dell appraisal rights matter. In the fourth quarter of 2018, we recognized an additional non-recurring $15.2 million reduction in operating expenses upon the recovery of a portion of the the payments made to our clients in prior years. Like in prior years, we believe it is useful to our readers of our consolidated statements of income to adjust for this non-recurring recovery in arriving at adjusted operating expenses, net operating income, provision for income taxes, net income attributable to T. Rowe Price Group and diluted earnings per share. |
(7) | The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 24.0% in 2019 and 24.1% in 2018. As such, the non-GAAP effective tax rate for the fourth quarter was 21.8% in 2019 and 25.4% in 2018. The firm estimates that its effective tax rate for the full-year 2020 on a non-GAAP basis will be in the range of 23.5% to 25.5%. |
(8) | This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows: |
Three months ended | Year ended | |||||||||||||
12/31/2019 | 12/31/2018 | 12/31/2019 | 12/31/2018 | |||||||||||
Adjusted net income attributable to T. Rowe Price Group | $ | 495.2 | $ | 384.0 | $ | 1,975.6 | $ | 1,807.4 | ||||||
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 13.3 | 9.5 | 50.9 | 42.5 | ||||||||||
Adjusted net income allocated to common stockholders | $ | 481.9 | $ | 374.5 | $ | 1,924.7 | $ | 1,764.9 | ||||||